Phase II trial of WT1 analog peptide vaccine in adults with acute myeloid leukemia (AML) in first complete remission (CR) Meeting Abstract
| Authors: | Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M. G.; Rosenblat, T. L.; Jurcic, J. G.; Rampal, R.; Park, J. H.; Douer, D.; Katz, L.; Gutierrez, A. A.; Tallman, M. S.; Scheinberg, D. A. |
| Abstract Title: | Phase II trial of WT1 analog peptide vaccine in adults with acute myeloid leukemia (AML) in first complete remission (CR) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 376s |
| Language: | English |
| ACCESSION: | WOS:000404711504141 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.7005 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 7005 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
